Detailed text transcripts for TV channel - MSNBC - 20170317:05:40:00
Namzaric is approved for moderate to severe alzheimers disease in patients who are taking donepezil. it may improve cognition and overall function, and may slow the worsening of symptoms for a while. namzaric does not change the underlying disease progression. dont take if allergic to memantine, donepezil, piperidine, or any of the ingredients in namzaric. tell the doctor about any conditions; including heart, lung, bladder, kidney or liver problems, seizures, stomach ulcers, or procedures with ...
Source: news source